FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (94 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1150/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150
Version 20240124
Status active
Date 2024-01-24T01:11:59-05:00
Name SubstanceUseDisorderShortActingMedication
Title Substance Use Disorder Short Acting Medication
Experimental False
Realm us
Authority hl7
Purpose (Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259 Substance Use Disorder Short Acting Medication


Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.1150",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2024-01-24T09:53:01.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "NCQA PHEMUR Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-01-24"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-01-24"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.1150"
    }
  ],
  "version" : "20240124",
  "name" : "SubstanceUseDisorderShortActingMedication",
  "title" : "Substance Use Disorder Short Acting Medication",
  "status" : "active",
  "date" : "2024-01-24T01:11:59-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:03ebf3e4-9f93-4b3b-bcf0-58064c74bbc2",
    "timestamp" : "2024-12-10T10:40:45-05:00",
    "total" : 21,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1010600",
        "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1010604",
        "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1307056",
        "display" : "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1307061",
        "display" : "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1431076",
        "display" : "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1431102",
        "display" : "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1483744",
        "display" : "naltrexone hydrochloride 50 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1542390",
        "display" : "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1544851",
        "display" : "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1544854",
        "display" : "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1597568",
        "display" : "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1597573",
        "display" : "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1666338",
        "display" : "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1864412",
        "display" : "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "197623",
        "display" : "disulfiram 250 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "197624",
        "display" : "disulfiram 500 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351264",
        "display" : "buprenorphine 2 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351265",
        "display" : "buprenorphine 8 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351266",
        "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351267",
        "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "835726",
        "display" : "acamprosate calcium 333 MG Delayed Release Oral Tablet"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.